Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race

6 days ago 18

Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer’s deal announced two weeks earlier.

Read Entire Article

Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race

Related

Summer doldrums are slowing stock trading — but don’t sell a...

Warner Bros. Discovery to split in two. What that means for ...

Energy tax credits give Americans good jobs and independence...

Trending

Popular

Circle Eyes $7.2B Valuation in Upsized U.S. IPO Amid Strong ...

China’s AI industry is booming. Can Nvidia and other U.S. co...

Trump ‘revenge tax’ may open new front in global trade war, ...

Coinbase aware of recently disclosed data leak since January...

Stocks will keep climbing during the summer, suggests this k...